When fine-needle aspiration biopsy cannot exclude papillary thyroid cancer: A therapeutic dilemma

Archives of Surgery

Volumn 141, Issue 10, 2006, Pages 961-966

  Mittendorf, Elizabeth A ^a   Khiyami, Amer ^b   McHenry, Christopher R ^b,c  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; CYTOLOGY; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; THYROID CANCER;

ADENOCARCINOMA; ADENOMA; ADULT; ALGORITHMS; BIOPSY, FINE-NEEDLE; FEMALE; FROZEN SECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33750064548     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.10.961     Document Type: Review

References (30)

1. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11,000 biopsies. Clin Lab Med. 1993;13:699-709.
2. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-289.
3. Caruso D, Mazzaferri EL. Fine-needle aspiration biopsy in the management of thyroid nodules. Endocrinologist. 1991;1:194-202.
4. Mittendorf EA, McHenry CR. Thyroid cancer. In: Cameron JL, ed. Current Surgical Therapy. 8th ed. Philadelphia, Pa: Elsevier Mosby; 2004:584-591.
5. DeMay R. Thyroid. In: DeMay R, ed. The Art and Science of Cytopathology. Chicago, Ill: ASCP Press; 1996:724-740.
6. Chen H, Zeiger MA, Clark DP, Westra WH, Udelsman R. Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration? J Am Coll Surg. 1997;184:605-610.
7. Sclabas GM, Staerkel GA, Shapiro SE, et al. Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg. 2003;186:702-710.
8. Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery. 1994;116:1054-1060.
9. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations and effect. Mayo Clin Proc. 1994;69:44-49.
10. Mittendorf EA, McHenry CR. Follow-up evaluation and clinical course of patients with benign nodular thyroid disease. Am Surg. 1999;65:653-658.
11. Lowhagen T, Granberg PO, Lundell G, Skinnari P, Sundblad R, Willems JS. Aspiration biopsy cytology in nodules of the thyroid gland suspected to be malignant. Surg Clin North Am. 1979;59:3-18.
12. Clark OH. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg. 1982;196:361-370.
13. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418-428.
14. McHenry CR, Raeburn C, Strickland T, Marty JJ. The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer. Am J Surg. 1996;172:658-661.
15. Hamburger JI, Hamburger SW. Declining role of frozen section in surgical planning for thyroid nodules. Surgery. 1985;98:307-312.
16. Logani S, Gupta PK, LiVolsi VA, Mandel S, Baloch ZW. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol. 2000;23:380-385.
17. McHenry CR, Slusarczyk SJ, Askari AT, et al. Refined use of scintigraphy in the evaluation of nodular thyroid disease. Surgery. 1998;124:656-661.
18. Ashcraft MW, Van Herle AJ. Management of thyroid nodules, I: history and physical examination, blood tests, x-ray tests, and ultrasonography. Head Neck Surg. 1981;3:216-230.
19. Ashcraft MW, Van Herle AJ. Management of thyroid nodules, II: scanning techniques, thyroid suppressive therapy, and fine-needle aspiration. Head Neck Surg. 1981;3:297-322.
20. Tyler DS, Shaha AR, Udelsman RA, et al. Thyroid cancer: 1999 update. Ann Surg Oncol. 2000;7:376-398.
21. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
22. Cohen Y, Xing M, Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst. 2003;95:625-627.
23. Fukushima T, Suzuki S, Mashiko M, et al. BRAF mutations in papillary carcinomas of the thyroid. Oncogene. 2003;22:6455-6457.
24. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63:1454-1457.
25. Namba H, Nakashima M, Hayashi T, et al. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab. 2003;88:4393-4397.
26. Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab. 2003;88:5399-5404.
27. Soares P, Trovisco V, Rocha AS, et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene. 2003;22:4578-4580.
28. Xing M, Vasko V, Tallini G, et al. BRAF T1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab. 2004;89:1365-1368.
29. Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res. 2003;63:4561-4567.
30. Xing M, Tufano RP, Tufaro AP, et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab. 2004;89:2867-2872.